Tiludronate for Paget's disease of bone.
D002986:Clinical Trials as Topic; D003967:Diarrhea / Q000139:chemically induced; D004164:Diphosphonates / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004311:Double-Blind Method; D006801:Humans; D009325:Nausea / Q000139:chemically induced; D010001:Osteitis Deformans / Q000188:drug therapy* / Q000378:metabolism; D014839:Vomiting / Q000139:chemically induced
D004164:Diphosphonates; C058651:tiludronic acid